Please read the following table in Markdown format and then answer the question according to the table. Table cells in one row are seperated by '|', and different rows are seperated by '
'.

Table:
| Name | Investigation | Route of administration | In-vitro / in-vivo | Imaging / non-imaging |
| --- | --- | --- | --- | --- |
| I123-Iodide | Thyroid uptake | Oral or IV | In-vivo | Non-imaging |
| I123-Iodide | Thyroid imaging Thyroid metastases imaging | Oral or IV | In-vivo | Imaging |
| I123-o-Iodohippurate | Renal imaging | IV | In-vivo | Imaging |
| I123-MIBG (m-iodobenzylguanidine) | Neuroectodermal tumour imaging | IV | In-vivo | Imaging |
| I123-FP-CIT | SPECT imaging of Parkinson's Disease | IV | In-vivo | Imaging |
Question:
What Name is administered by oral or iv, and is being investigated for thyroid imaging thyroid metastases imaging?
Answer:
I123-Iodide